Big Pharma Bribery: Top Celebrity Doctors Paid by GlaxoSmithKline to Push Drugs

Lisa Gerber
Prisonplanet.com
July 4, 2012

Famed radio host and television personality Dr. Drew Pinskey—or just Dr. Drew—is one of the many physicians and ‘celebrity doctors’ accused of accepting money from the recently exposed pharmaceutical giant GlaxoSmithKline as incentive to push the antidepressant Wellbutrin.

Recently, the US government charged Glaxo with multiple misdemeanor criminal charges. These charges include Glaxo’s promotion of—and bribing professionals like Pinskey to promote—Wellbutrin for uses they failed to confirm with the Food and Drug Administration. Glaxo is paying a landmark fee of $3 billion in civil and criminal settlement charges.

Their email from Tuesday made no comments on their relationship with Pinskey but did add, “The complaint to which you refer concerns events in 1999.”

By 1999, Pinskey had already developed a sort of stardom as the co-host of Loveline. The radio and call-in TV show moved to MTV in 1996. You might also remember him from his hallmark show Dr. Drew or Celebrity Rehab with Dr. Drew.

Despite being somewhat thrown under the bus by Glaxo, Pinskey insists his hands are clean. “In the late ‘90s I was hired to participate in a two-year initiative discussing intimacy and depression which was funded by an educational grant by Glaxo Wellcome [one of the companies that merged to form GSK]…. My comments were consistent with my clinical experience.”

Off-Label Claims by Paid Celebrity Doctors

Another physician facing scrutiny is James Pradko, who also made “off-label” claims about Wellbutrin including its effectiveness in weight management, chronic fatigue syndrome, erectile dysfunction, and chemical dependences. Dr. Pradko declared in a phone interview on Tuesday that the complaints against him were out of context and his own comments “weren’t meant to sell drugs, ever.”

Court records note Pinskey also made “off-label” claims about the drug. In example, Wellbutrin is approved by the FDA only as an antidepressant, but Pinskey has been recorded saying that its ingredients “could explain a woman suddenly having 60 orgasms in one night.” Pinskey has also plugged for a Glaxo-affiliated website.

The Justice Department is to believe, of course, that Pinskey’s antics had nothing to do with the invoice to GSK for $275,000.

Sources used for this article:

Wall Street Journal

The Daily Beast

This post first appeared at Natural Society

View the original article here

FDA Approves Meningitis Vaccine After Big Pharma Conducts Human Experiments

Susanne Posel
Prisonplanet.com
June 25, 2012

The Food and Drug Administration (FDA) has given GlaxoSmithKilne (GSK) their approval of the MenHibrix vaccine(MHV), which is meant for infants between the ages of 6 weeks to 18 months. This vaccine is a dangerous mixture of the meningococcal disease and Hib disease.

MHV will be manufactured in Rixensart, a Belgium-based arm of GSK Biologicals.

In 2010 and 2011, the FDA rejected MHV. GSK claims that they have “resolved” the FDA’s concerns about the necessity, potency and efficiency of MHV. This simply accepted GSK’s word that they have taken care of the vaccine’s issues. The FDA does not require more proof than that.

In fact, the FDA’s standard practice is to regulate drugs after they have been approved, rather than just making sure they are safe before releasing them out to the public.

In 2008, the FDA admitted that there is no regulatory checking of safety of trials. The FDA relied solely on the data provided them from the drug makers themselves.

Furthermore, the FDA does not check or regulate cosmetics prior to their release to the markets for the public to purchase. They leave the safety responsibility to the cosmetic corporations to essentially regulate themselves.

According to the Centers for Disease Control and Prevention (CDC), infants are most at risk for contracting bacterial meningitis, which is an infection that attacks the thin lining surrounding the brain and spinal cord.
Last month, the CDC was involved in a propaganda campaign to coerce Americans to start receiving immunizations after the recent decline reported by doctors across the country.

Karen Midthum, director of the center for biologics at the FDA stated that:

With today’s approval of Menhibrix, there is now a combination vaccine that can be used to prevent potentially life-threatening Hib disease and two types of meningococcal disease in children. It is the first meningococcal vaccine that can be given starting as young as six weeks of age.

The MHV will be administered as a four-dose vaccine that the CDC recommended is added to infant’s immunizations schedule.

Dr. Leo Friedland, vice president of clinical and medical affairs at GSK North American division says:

(Meningitis) is one of those diseases that although not common, when it occurs it’s absolutely devastating and horrible. It presents to the doctor when a child just looks ill, and within 18 to 24 hours, they’re on the deathbed in the hospital. . . To be able to have a vaccine to prevent meningitis is really a great day.

The MHV targets only the C and Y strains of meningococcal bacteria and the Hib bacteria (a.k.a. Haemophilus influenzae type b).

GSK says there is no vaccine in the US to treat the B strain of the meningococcal bacteria.GSK is planning on administering 1.1 billion doses of MHV to 173 countries in developed and developing countries.GSK maintains that MHV was evaluated on 7,500 infants and toddlers in the U.S., Mexico and Austria.

Pfizer, one of GSK’s biggest competitors, was part of a campaign in Southern Africa and India where they were conducting experiments with their meningitis vaccine on underdeveloped children in nations where their access to healthcare is severely limited.

This experiment was perfectly timed. While a meningitis epidemic broke out in Nigeria, Pfizer happen to coincide this problem with the reveal of Trovan, which was distributed to Nigerians in response to the “outbreak”.

To receive the Food and Drug Administration’s certification of approval, Pfizer used Africa as their clinical trial laboratory to produce the proof they needed to make Trovan a profitable endeavor.

The St. Louis University’s (SLU) Center for Vaccine Development (CVD) is conducting a study with Pfizer, to create a vaccine for meningitis specifically targeting children.

Dr. Edwin Anderson, researcher at SLU’s CVD states:

An effective adolescent vaccine against meningococcal B disease has the potential to help save lives and reduce emotional and psychological stress caused by long-term consequences of the disease.

This vaccine will target the human immune system, our body’s natural defense against disease. Their purpose is to find an effective way of tricking the human immune system. Traditional use of dead cultures in this instance is ineffective, says Anderson.

Because of the adverse reactions, the use of live cultures of dangerous diseases and the proven ineffectual nature of vaccines, this rush to find a meningitis vaccine targeting our children is simply another attempt by Big Pharma to undermine our natural ability to remain healthy.

Susanne Posel is the Chief Editor of Occupy Corporatism. Our alternative news site is dedicated to reporting the news as it actually happens; not as it is spun by the corporately funded mainstream media. You can find us on our Facebook page.

 

View the original article here

FDA Approves Meningitis Vaccine After Big Pharma Conducts Human Experiments

Susanne Posel
Infowars.com
June 23, 2012

The Food and Drug Administration (FDA) has given GlaxoSmithKilne (GSK) their approval of the MenHibrix vaccine (MHV), which is meant for infants between the ages of 6 weeks to 18 months. This vaccine is a dangerous mixture of the meningococcal disease and Hib disease.

MHV will be manufactured in Rixensart, a Belgium-based arm of GSK Biologicals.

In 2010 and 2011, the FDA rejected MHV. GSK claims that they have “resolved” the FDA’s concerns about the necessity, potency and efficiency of MHV. This simply involved GSK’s word that they have taken care of the vaccine’s issues. The FDA does not require more proof than that.

In fact, the FDA’s standard practice is to regulate drugs after they have been approved by, rather than just making sure they are safe before releasing them out to the public.

In 2008, the FDA admitted that there is no regulatory checking of safety of trials. The FDA relied solely on the data provided them from the drug makers themselves.

Furthermore, the FDA does not check or regulate cosmetics prior to their release to the markets for the public to purchase. They leave the safety responsibility to the cosmetic corporations to essentially regulate themselves.

According to the Centers for Disease Control and Prevention (CDC), infants are most at risk for contracting bacterial meningitis, which is an infection that attacks the thin lining surrounding the brain and spinal cord.

Last month, the CDC was involved in a propaganda campaign to coerce Americans to start receiving immunizations after the recent decline reported by doctors across the country.

Karen Midthum , director of the center for biologics at the FDA stated that “with today’s approval of Menhibrix, there is now a combination vaccine that can be used to prevent potentially life-threatening Hib disease and two types of meningococcal disease in children. It is the first meningococcal vaccine that can be given starting as young as six weeks of age.”

The MHV will be administered as a four-dose vaccine that the CDC recommended is added to infant’s immunizations schedule.

Dr. Leo Friedland , vice president of clinical and medical affairs at GSK North American division says: “(Meningitis) is one of those diseases that although not common, when it occurs it’s absolutely devastating and horrible. It presents to the doctor when a child just looks ill, and within 18 to 24 hours, they’re on the deathbed in the hospital. . . To be able to have a vaccine to prevent meningitis is really a great day.”

The MHV targets only the C and Y strains of meningococcal bacteria and the Hib bacteria (a.k.a. Haemophilus influenzae type b).

GSK says there is no vaccine in the US to treat the B strain of the meningococcal bacteria.

GSK is planning on administering 1.1 billion doses of MHV to 173 countries in developed and developing countries.

GSK maintains that MHV was evaluated on 7,500 infants and toddlers in the U.S., Mexico and Austria.

Pfizer, one of GSK’s biggest competitors, was part of a campaign in Southern Africa and India where they were conducting experiments with their meningitis vaccine on under – developed children in nations where their access to healthcare is severely limited.

This experiment was perfectly timed. While a meningitis epidemic broke out in Nigeria, Pfizer happen to coincide this problem with the reveal of Trovan, which was distributed to Nigerians in response to the “outbreak”.

To receive the Food and Drug Administration’s certification of approval, Pfizer used Africa as their clinical trial laboratory to produce the proof they needed to make Trovan a profitable endeavor.

The St. Louis University’s (SLU) Center for Vaccine Development (CVD) is conducting a study with Pfizer, to create a vaccine for meningitis specifically targeting children.

Dr. Edwin Anderson, researcher at SLU’s CVD states: “An effective adolescent vaccine against meningococcal B disease has the potential to help save lives and reduce emotional and psychological stress caused by long-term consequences of the disease.”

This vaccine will target the human immune system, our body’s natural defense against disease. Their purpose is to find an effective way of tricking the human immune system. Traditional use of dead cultures in this instance is ineffective, says Anderson.

Because of the adverse reactions, the use of live cultures of dangerous diseases and the proven ineffectual nature of vaccines, this rush to find a meningitis vaccine targeting our children is simply another attempt by Big Pharma to undermine our natural ability to remain healthy.

—————–
This article first appeared on Susanne Posel’s website Occupy Corporatism.

Tags: Government Corruption, Police state, Vaccines

View the original article here